P-glycoprotein inhibitor HM30181AK
Term · Oncology and biomedicine · MLC-T-ONC-016000
An inhibitor of the adenosine triphosphate (ATP)-binding cassette (ABC) transporter P-glycoprotein (P-gp), with adjuvant activity. Upon oral administration, P-gp inhibitor HM30181AK selectively binds to and inhibits the multidrug resistance (MDR) efflux pump P-gp, which prevents the efflux of various chemotherapeutic agents from intestinal epithelial cells to the gastrointestinal tract. This leads to an increase in both oral bioavailability and therapeutic efficacy. P-gp prevents the intestinal uptake and intracellular accumulation of various cytotoxic agents. HM30181AK is not systemically absorbed.
| Identifier | MLC-T-ONC-016000 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Pgp inhibitor HM30181AK |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016000",
"term": "P-glycoprotein inhibitor HM30181AK",
"field": "Oncology and biomedicine",
"definition": "An inhibitor of the adenosine triphosphate (ATP)-binding cassette (ABC) transporter P-glycoprotein (P-gp), with adjuvant activity. Upon oral administration, P-gp inhibitor HM30181AK selectively binds to and inhibits the multidrug resistance (MDR) efflux pump P-gp, which prevents the efflux of various chemotherapeutic agents from intestinal epithelial cells to the gastrointestinal tract. This leads to an increase in both oral bioavailability and therapeutic efficacy. P-gp prevents the intestinal uptake and intracellular accumulation of various cytotoxic agents. HM30181AK is not systemically absorbed.",
"synonyms": [
"Pgp inhibitor HM30181AK"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/p-glycoprotein-inhibitor-hm30181ak/"
}
Record 13,063 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.